Total Raised

$75.96M

Investors Count

11

Deal Terms

2

Funding, Valuation & Revenue

14 Fundings

OpenGamma has raised $75.96M over 14 rounds.

OpenGamma's latest funding round was a Acquired for on December 17, 2025.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

12/17/2025

Acquired

$XXM

0

FY undefined

3

2/1/2022

Series F

$21M

$XXM

0

FY undefined

6

4/3/2019

Series E

$10M

$XXM

0

FY undefined

5

2/1/2017

Corporate Minority

$XXM

$XXM

0

FY undefined

10

10/5/2016

Series D

$XXM

$XXM

0

FY undefined

10

Date

12/17/2025

2/1/2022

4/3/2019

2/1/2017

10/5/2016

Round

Acquired

Series F

Series E

Corporate Minority

Series D

Amount

$21M

$10M

$XXM

$XXM

Investors

Valuation

$XXM

$XXM

$XXM

$XXM

$XXM

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

3

6

5

10

10

Start free trial
New call-to-action

OpenGamma Deal Terms

2 Deal Terms

OpenGamma's deal structure is available for 2 funding rounds, including their Series B from January 17, 2011.

Round

Series B

Series A

Funding Date

$XXM

$XXM

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$XXM

$XXM

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$XXM

$XXM

Board Voting

$XXM

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

$XXM

$XXM

$XXM

$XXM

Series A

$XXM

$XXM

$XXM

$XXM

OpenGamma Investors

11 Investors

OpenGamma has 11 investors. Trading Technologies invested in OpenGamma's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

12/17/2025

12/17/2025

1
Acquired

Corporation

Illinois

1/17/2011

2/1/2022

6
Series A, Series B (2011), Series C (2012), Series D (2016), Series E (2019), Series F (2022)

Venture Capital

California

1/17/2011

2/1/2022

4
Series A, Series B (2011), Series C (2012), Series F (2022)

Venture Capital

New York

00/00/0000

00/00/0000

Euclid Opportunities

Subscribe to see more

Corporate Venture

United Kingdom

00/00/0000

00/00/0000

CME Ventures

Subscribe to see more

Corporate Venture

Illinois

First funding

12/17/2025

1/17/2011

1/17/2011

00/00/0000

00/00/0000

Last Funding

12/17/2025

2/1/2022

2/1/2022

00/00/0000

00/00/0000

Investor

Euclid Opportunities

CME Ventures

Rounds

1
Acquired
6
Series A, Series B (2011), Series C (2012), Series D (2016), Series E (2019), Series F (2022)
4
Series A, Series B (2011), Series C (2012), Series F (2022)

Subscribe to see more

Subscribe to see more

Board Seats

Type

Corporation

Venture Capital

Venture Capital

Corporate Venture

Corporate Venture

Location

Illinois

California

New York

United Kingdom

Illinois

New call-to-action

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.